These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 9753035

  • 1. Functional, phenotypic and molecular characterization of cytokine low-responding circulating CD34+ haemopoietic progenitors.
    Pierelli L, Scambia G, Fattorossi A, Bonanno G, Battaglia A, Rumi C, Marone M, Mozzetti S, Rutella S, Menichella G, Romeo V, Mancuso S, Leone G.
    Br J Haematol; 1998 Sep; 102(5):1139-50. PubMed ID: 9753035
    [Abstract] [Full Text] [Related]

  • 2. High cyclin-dependent kinase inhibitors in Bcl-2 and Bcl-xL-expressing CD34+-proliferating haematopoietic progenitors.
    Marone M, Pierelli L, Mozzetti S, Masciullo V, Bonanno G, Morosetti R, Rutella S, Battaglia A, Rumi C, Mancuso S, Leone G, Giordano A, Scambia G.
    Br J Haematol; 2000 Sep; 110(3):654-62. PubMed ID: 10997978
    [Abstract] [Full Text] [Related]

  • 3. CD34+/CD105+ cells are enriched in primitive circulating progenitors residing in the G0 phase of the cell cycle and contain all bone marrow and cord blood CD34+/CD38low/- precursors.
    Pierelli L, Scambia G, Bonanno G, Rutella S, Puggioni P, Battaglia A, Mozzetti S, Marone M, Menichella G, Rumi C, Mancuso S, Leone G.
    Br J Haematol; 2000 Mar; 108(3):610-20. PubMed ID: 10759721
    [Abstract] [Full Text] [Related]

  • 4. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM, Tafuri A, Fortuna A, Catani L, Rondelli D, Ratta M, Tura S.
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [Abstract] [Full Text] [Related]

  • 5. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

  • 6. Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media.
    Shaw PH, Olszewski M, Kletzel M.
    J Hematother Stem Cell Res; 2001 Jun; 10(3):391-403. PubMed ID: 11454314
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [Abstract] [Full Text] [Related]

  • 8. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM, Fortuna A, Fogli M, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [Abstract] [Full Text] [Related]

  • 9. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
    Simmons PJ, Aylett GW, Niutta S, To LB, Juttner CA, Ashman LK.
    Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
    [Abstract] [Full Text] [Related]

  • 10. Differential modulation of adhesion markers with ex vivo expansion of human umbilical CD34+ progenitor cells.
    Reems JA, Mielcarek M, Torok-Storb B.
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):133-41. PubMed ID: 9310190
    [Abstract] [Full Text] [Related]

  • 11. Flt 3 ligand, MGDF, Epo and G-CSF enhance ex vivo expansion of hematopoietic cell compartments in the presence of SCF, IL-3 and IL-6.
    Kobari L, Giarratana MC, Poloni A, Firat H, Labopin M, Gorin NC, Douay L.
    Bone Marrow Transplant; 1998 Apr; 21(8):759-67. PubMed ID: 9603398
    [Abstract] [Full Text] [Related]

  • 12. Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34+DR- dendritic cell precursors.
    Curti A, Fogli M, Ratta M, Tura S, Lemoli RM.
    J Immunol; 2001 Jan 15; 166(2):848-54. PubMed ID: 11145659
    [Abstract] [Full Text] [Related]

  • 13. CD105 (endoglin) expression on hematopoietic stem/progenitor cells.
    Pierelli L, Bonanno G, Rutella S, Marone M, Scambia G, Leone G.
    Leuk Lymphoma; 2001 Jan 15; 42(6):1195-206. PubMed ID: 11911400
    [Abstract] [Full Text] [Related]

  • 14. High-resolution cell division tracking demonstrates the FLt3-ligand-dependence of human marrow CD34+CD38- cell production in vitro.
    Nordon RE, Ginsberg SS, Eaves CJ.
    Br J Haematol; 1997 Sep 15; 98(3):528-39. PubMed ID: 9332305
    [Abstract] [Full Text] [Related]

  • 15. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I, Steidl U, Fischer JC, Czibere A, Kobbe G, Raschke S, Singh R, Fenk R, Rosskopf M, Pechtel S, von Haeseler A, Wernet P, Tenen DG, Haas R, Kronenwett R.
    Haematologica; 2008 Mar 15; 93(3):347-55. PubMed ID: 18268278
    [Abstract] [Full Text] [Related]

  • 16. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L, Giarratana MC, Pflumio F, Izac B, Coulombel L, Douay L.
    J Hematother Stem Cell Res; 2001 Apr 15; 10(2):273-81. PubMed ID: 11359674
    [Abstract] [Full Text] [Related]

  • 17. Purified unfractionated G-CSF/chemotherapy mobilized CD34+ peripheral blood progenitors and not bone marrow CD34+ progenitors undergo selective erythroid differentiation in liquid culture in the presence of erythropoietin and stem cell factor.
    Pierelli L, Scambia G, Menichella G, Fattorossi A, Ciarli M, Bonanno G, Battaglia A, d'Onofrio G, Benedetti Panici P, Iacone A, Mancuso S, Leone G.
    Br J Haematol; 1997 Jan 15; 96(1):55-63. PubMed ID: 9012687
    [Abstract] [Full Text] [Related]

  • 18. The expansion of megakaryocyte progenitors from CD34+-enriched mobilized peripheral blood stem cells is inhibited by Flt3-L.
    Case J, Hicks C, Trickett A, Kwan YL, Manoharan A.
    J Interferon Cytokine Res; 2006 Feb 15; 26(2):76-82. PubMed ID: 16487027
    [Abstract] [Full Text] [Related]

  • 19. Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF).
    Catani L, Gugliotta L, Campanini E, Mangianti S, Gibellini D, Baravelli S, Vianelli N, Lemoli RM, Tura S.
    Br J Haematol; 1998 Jan 15; 100(1):207-18. PubMed ID: 9450813
    [Abstract] [Full Text] [Related]

  • 20. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
    Reid CD, Stackpoole A, Meager A, Tikerpae J.
    J Immunol; 1992 Oct 15; 149(8):2681-8. PubMed ID: 1383322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.